Endocrine-disrupting Chemicals and Epigenetic Reprogramming in Developmental Origin of Uterine Fibroids

Overview

Journal Sci Prog

Publisher Sage Publications

Specialty Science

Date 2024 Jan 8

PMID 38189295

Authors

Qiwei Yang

Mohamed Ali

Maria Victoria Bariani

Somayeh Vafaei

Ayman Al-Hendy

Affiliations

Soon will be listed here.

Abstract

Endocrine-disrupting chemicals (EDCs) are a class of exogenous substances that mimic the effects of hormones in the body, inducing hormonal dysregulation and contributing to various disorders. Epigenome regulation has emerged as an important mechanism for maintaining organ function in health and disease. Dissecting epigenomic and resultant gene expression changes provides unprecedented insight into the chromatin state, which underlines disease development and shapes risk and phenotypic plasticity in response to the environment and internal cues. The cutting-edge, high throughput technologies provide new routes to understanding the etiology of disease and new footholds on the promising path to better treatment and disease prevention. We have recently revealed that myometrial stem cells (MMSCs), the cell origin of UFs, are the target of developmental EDC exposure. The EDC-induced epigenetic changes in MMSCs identified by multi-omics approaches include DNA methylation and histone modification modulated by DNA methyltransferases and MLL1, which characterized the molecular mechanism underlying EDC-related risk in hormone-dependent UFs. Future studies are needed to determine the link between real-life exposures to EDCs and their impact on the development of human diseases and transgenerational epigenetic inheritance, which can help explore strategies that may prevent adverse outcomes linked to EDC exposure.

Citing Articles

Hair Straightener Use in Relation to Prevalent and Incident Fibroids in the Sister Study with a Focus on Black Women.

Ogunsina K, OBrien K, White A, Chang C, Gaston S, Jackson C Environ Health Perspect. 2025; 133(1):17004.

PMID: 39808082 PMC: 11730732. DOI: 10.1289/EHP14493.

Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy.

Yang Q, Madueke-Laveaux O, Cun H, Wlodarczyk M, Garcia N, Carvalho K Cells. 2024; 13(13.

PMID: 38994959 PMC: 11240800. DOI: 10.3390/cells13131106.

References

Hu W, Hu D, Xie L, Nonn L, Lu R, Abern M . Keratin Profiling by Single-Cell RNA-Sequencing Identifies Human Prostate Stem Cell Lineage Hierarchy and Cancer Stem-Like Cells. Int J Mol Sci. 2021; 22(15). PMC: 8346986. DOI: 10.3390/ijms22158109. View

Yang Q, Ciebiera M, Bariani M, Ali M, Elkafas H, Boyer T . Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2021; 43(4):678-719. PMC: 9277653. DOI: 10.1210/endrev/bnab039. View

Ono M, Qiang W, Serna V, Yin P, Coon 5th J, Navarro A . Role of stem cells in human uterine leiomyoma growth. PLoS One. 2012; 7(5):e36935. PMC: 3343011. DOI: 10.1371/journal.pone.0036935. View

Elkafas H, Ali M, Elmorsy E, Kamel R, Thompson W, Badary O . Vitamin D3 Ameliorates DNA Damage Caused by Developmental Exposure to Endocrine Disruptors in the Uterine Myometrial Stem Cells of Eker Rats. Cells. 2020; 9(6). PMC: 7349254. DOI: 10.3390/cells9061459. View

Cook J, Davis B, Cai S, Barrett J, Conti C, Walker C . Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci U S A. 2005; 102(24):8644-9. PMC: 1150843. DOI: 10.1073/pnas.0503218102. View

Mas A, Nair S, Laknaur A, Simon C, Diamond M, Al-Hendy A . Stro-1/CD44 as putative human myometrial and fibroid stem cell markers. Fertil Steril. 2015; 104(1):225-34.e3. PMC: 4490118. DOI: 10.1016/j.fertnstert.2015.04.021. View

Visvader J, Lindeman G . The unmasking of novel unipotent stem cells in the mammary gland. EMBO J. 2011; 30(24):4858-9. PMC: 3243632. DOI: 10.1038/emboj.2011.415. View

Bariani M, Rangaswamy R, Siblini H, Yang Q, Al-Hendy A, Zota A . The role of endocrine-disrupting chemicals in uterine fibroid pathogenesis. Curr Opin Endocrinol Diabetes Obes. 2020; 27(6):380-387. PMC: 8240765. DOI: 10.1097/MED.0000000000000578. View

Crowley L, Cambuli F, Aparicio L, Shibata M, Robinson B, Xuan S . A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors. Elife. 2020; 9. PMC: 7529463. DOI: 10.7554/eLife.59465. View

10.

Yang Q, Ali M, Trevino L, Mas A, Ismail N, Al-Hendy A . Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids. Int J Mol Sci. 2023; 24(14). PMC: 10380326. DOI: 10.3390/ijms241411641. View

11.

Yang Q, Ali M, Trevino L, Mas A, Al-Hendy A . Developmental reprogramming of myometrial stem cells by endocrine disruptor linking to risk of uterine fibroids. Cell Mol Life Sci. 2023; 80(9):274. PMC: 10471700. DOI: 10.1007/s00018-023-04919-0. View

12.

Prusinski Fernung L, Yang Q, Sakamuro D, Kumari A, Mas A, Al-Hendy A . Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells. Biol Reprod. 2018; 99(4):735-748. PMC: 6203880. DOI: 10.1093/biolre/ioy097. View

13.

Iizuka T, Yin P, Zuberi A, Kujawa S, Coon 5th J, Bjorvang R . Mono-(2-ethyl-5-hydroxyhexyl) phthalate promotes uterine leiomyoma cell survival through tryptophan-kynurenine-AHR pathway activation. Proc Natl Acad Sci U S A. 2022; 119(47):e2208886119. PMC: 9704719. DOI: 10.1073/pnas.2208886119. View

14.

Bariani M, Cui Y, Ali M, Bai T, Grimm S, Coarfa C . TGFβ signaling links early life endocrine-disrupting chemicals exposure to suppression of nucleotide excision repair in rat myometrial stem cells. Cell Mol Life Sci. 2023; 80(10):288. PMC: 10492698. DOI: 10.1007/s00018-023-04928-z. View

15.

Mas A, Stone L, OConnor P, Yang Q, Kleven D, Simon C . Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis. Stem Cells. 2016; 35(3):666-678. DOI: 10.1002/stem.2519. View